Dear MEL Topic Readers,
First malaria treatment for babies approved for use
Malaria is a mosquito-borne infectious disease caused by a parasite. It
is mostly found in tropical regions such as Africa and South Asia. Symptoms include
fever, chills, and headaches, and in more severe cases, fatigue, seizures, and difficulty
breathing. It is preventable and curable, but it is also life-threatening. Nearly
600,000 people died of malaria in 2023 alone, mostly in sub-Saharan Africa, and
three out of four of them were children under five years old. Properly and
timely provided medical treatments can stop mild symptoms from getting severe. Until
now, babies and young children have been treated with medicine formulated for
older children, which presents an overdose and other risks. Recently, a new medicine
designed for babies and young children was approved by the Swiss authorities.
The developer, a pharmaceutical giant, Novartis, is ready to roll out on a
non-profit basis. How many young lives will be saved?
Read the article and learn about the new medicine to treat malaria-infected
young children.
No comments:
Post a Comment